Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

East African Pharmaceutical Market 2017-2021 - Generic Pharmaceutical Products Continue to Dominate - Research and Markets

Research and Markets
Posted on: 01 Nov 17

The "East African Pharmaceutical Market, Forecast to 2021" report has been added to Research and Markets' offering.

Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities for growth in the pharmaceutical sector. While control and eradication of communicable diseases has been an ongoing priority area for governments, non-communicable diseases have now become an area of concern for the continent. This is driven by various factors that are mentioned in this study. In East Africa, the outlook of the healthcare environment is similar to that of the rest of Africa.

The countries generally share similar climate conditions, language, and disease prevalence. While significant strides have been made in healthcare provision, funding, infrastructure development and technology, the pharmaceutical sector in the region as a whole in East Africa is still much smaller than that of other regions in Africa, even though it has a higher population. Significant investments by multinational companies are driving growth using different proven business models.

The focus on universal healthcare, providing coverage for each citizen, particularly the poor and vulnerable, is a focal point for governments. With multiple participants in the region, including emerging leaders with high growth rates in the continent, pharmaceuticals in the region will now become more important than ever in the drive for better healthcare and the effort to meet millennium development goals. Some therapeutic areas in the countries under this study are now growing, giving an indication of future pharmaceutical opportunities.

The study covers the following pharmaceutical segments: cardiovascular, oncology, respiratory, anti-infective, and central nervous system.

Key Topics Covered:

1. Executive Summary

2. Market Overview

3. Drivers And Restraints - Total Pharmaceutical Market

4. Forecasts And Trends - Total Pharmaceutical Market

5. Growth Opportunities And Companies To Action

6. Kenya Analysis

7. Tanzania Analysis

8. Ethiopia Analysis

9. Uganda Analysis

10. Rwanda Analysis

11. The Last Word

12. Appendix

Companies Mentioned

  • AstraZeneca
  • Bayer
  • Bilim
  • Biodeal
  • CSPC
  • Cadila
  • Cipla
  • Cosmos
  • Denk
  • GSK
  • Julphar
  • Kampala Pharmaceutical Industries
  • Lab and Allied
  • Medipharm
  • Merck
  • Novartis
  • Pfizer
  • Ranbaxy
  • Regal
  • Roche
  • Sandoz
  • Shelys
  • Shreechem
  • Sterop
  • Universal

For more information about this report visit

View source version on

Business Wire

Last updated on: 01/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.